106 - Bright Spot Among CRISPR in Caribou Biosci. 2022 Biotech Trends to Watch!

Поділитися
Вставка
  • Опубліковано 15 гру 2024

КОМЕНТАРІ • 10

  • @jasondavis2810
    @jasondavis2810 2 роки тому +1

    Great channel buddy

  • @jasondavis2810
    @jasondavis2810 2 роки тому

    This channel has such fantastic content there should be hundreds of thousands of subs

    • @breakingbiotech
      @breakingbiotech  2 роки тому

      Appreciate the kind words. SELB had a wild week last week. I like them for H2. When I get time I'll look into them and maybe do a quick recap.

  • @stanhan2006
    @stanhan2006 2 роки тому +2

    1 second ago
    Matthew, Thank you for the great show and I enjoyed your insight on Oncology. Have pdsb, ckpt and mdgl, hope they don’t fall on result releases. Another area worth more attention is CNS space. Two companies caught my eyes-- DMAC & NGENF. I believe these are much more promising than most of the oncology companies. I’m hoping these two could attract your attention too. Hope you a successful 2022.

  • @hmbkw
    @hmbkw 2 роки тому +3

    Thank you Matthew for putting great content. I’m long Curis and hoping XBI will reverse going forward in 2022

  • @babykailan
    @babykailan 2 роки тому +1

    Great summary as always!

  • @bekincai
    @bekincai 2 роки тому +1

    thanks Matt I needed that. the drop in CRIS was a real kick in the nads. I really like your thoughts on the new patients have not been on drug that long and hopefully in a few months the ORR comes up a bit. if not I'm gonna be holding a much bigger bag than I am now. I still can't wrap my head around the data being in line with expectations and it tanks.

    • @breakingbiotech
      @breakingbiotech  2 роки тому

      That drop really hurt me too, but I think patience will pay off here. I'm very long the stock myself.

  • @jasondavis2810
    @jasondavis2810 2 роки тому +1

    Please get Timothy Springer on the show

  • @tigerkiller2832
    @tigerkiller2832 2 роки тому +1

    RNA(MRNA RANI SiRNA) tho must include those